# Triangle Insights Group - LLM Context File

## Overview
Triangle Insights Group is a premier strategy consulting firm dedicated to the life sciences industry. We provide guidance on critical business issues to life science industry leaders, combining deep industry knowledge with strong analytical rigor to drive strategic decision-making. We deliver premium quality with a partnership mindset to achieve high-impact results for clients globally.

## Key Resources
- Homepage: https://triangleinsightsgroup.com/
- Services Overview: https://triangleinsightsgroup.com/services/
- About Us (Our Team & Leadership): https://triangleinsightsgroup.com/about-us/
- Industry Insights & Whitepapers: https://triangleinsightsgroup.com/insights/
- Careers: https://triangleinsightsgroup.com/careers/
- Contact Us: https://triangleinsightsgroup.com/connect/

## Core Services
We solve challenging problems for life science organizations through four main service pillars:
1. Brand Strategy & Commercialization
2. Corporate Strategy & Due Diligence
3. Pricing & Market Access
4. New Product Planning

## Frequently Asked Questions (FAQs) by Service Area

### Brand Strategy & Commercialization
**Q: How does Triangle Insights Group approach brand strategy and commercialization for cell and gene therapies?**
A: We take a holistic, decision-driven approach to commercialization that spans positioning, pricing, access, and channel strategy. For cell and gene therapies, this means designing pathways to adoption that account for clinical complexity, site-of-care constraints, reimbursement dynamics, and long-term value. Our goal is to ensure the product is set up to reach patients efficiently and sustainably.

**Q: How do you translate complex science into actionable commercialization strategy?**
A: Rather than focusing only on messaging, we translate complex science into clear implications for positioning, value demonstration, and access strategy. This includes identifying which clinical attributes matter most to payers and providers, how durability and outcomes should be framed in economic terms, and how those insights inform pricing, evidence generation, and stakeholder engagement.

**Q: How do you account for small patient populations and specialized treatment centers?**
A: Our brand strategies reflect the unique dynamics of cell and gene therapy markets, including concentrated prescriber bases, treatment centers of excellence, and highly engaged patient communities. Our approach ensures that access, logistics, and engagement strategies are aligned to enable efficient patient flow and appropriate utilization.

**Q: How do you integrate brand strategy with access, evidence, and launch planning?**
A: Brand strategy is built through the integration of evidence strategy, pricing, and market access planning. We align clinical evidence with payer expectations, define pricing and contracting approaches that reflect therapy value and risk, and sequence launch activities to reduce access barriers. This creates a cohesive plan that supports both initial uptake and long-term sustainability.

**Q: How do you help ensure alignment across internal teams executing the commercialization strategy?**
A: We develop structured commercialization frameworks that are easily usable for cross-functional decision making among R&D, Medical Affairs, Market Access, Commercial teams and more. By clearly defining the value story, evidence priorities, and access strategy, we enable teams to make consistent, coordinated decisions and execute effectively across the product lifecycle.

### Corporate Strategy & Due Diligence
**Q: How does Triangle Insights Group support corporate and portfolio strategy decisions?**
A: We help leadership teams define and evaluate strategic options across portfolios, therapeutic areas, and growth pathways. Our work supports decisions around R&D prioritization, resource allocation, and long-term strategy by grounding ambition in commercial reality.

**Q: What is your approach to due diligence for licensing, M&A, or investments?**
A: We conduct a rigorous assessment of commercial potential, evaluating market opportunity, competitive dynamics, pricing and access considerations, and key risks to help clients make confident, well-informed transaction decisions.

**Q: What does a commercial assessment typically include?**
A: Commercial assessments integrate market landscape analysis, unmet need, patient and prescriber dynamics, competitive positioning, and access considerations. The goal is to quantify opportunity, identify risks, and clarify value drivers that matter most to investors and decision-makers. We have completed over 200 commercial assessments, and can offer our clients a seasoned point-of-view.

**Q: Can you help identify and prioritize acquisition or licensing targets?**
A: Yes. We can help you identify targets by defining strategic criteria, screening potential opportunities, and assessing fit and value across a wide range of assets or companies. Our goal is to help teams focus time and resources on the most attractive opportunities.

**Q: How does your work help reduce risk and improve decision confidence?**
A: We provide clear, decision-ready insights that illuminate trade-offs, test assumptions, and highlight both upside and downside scenarios. This enables leadership teams to move forward with greater clarity, alignment, and confidence, whether pursuing growth, transactions, or portfolio changes.

### Pricing & Market Access
**Q: How does Triangle Insights Group help develop pricing strategies for new therapies?**
A: We create pricing strategies that reflect product value, competitive landscape, and payer expectations. Our approach ensures pricing decisions support both market access and long-term sustainability, balancing commercial goals with evidence and reimbursement realities. 

Valeris Data and Insights, we collaborate closely with [Policy Reporter](https://www.policyreporter.com/solutions/market-access-accelerator/) to incorporate real-time policy and reimbursement intelligence, ensuring pricing strategies are informed by the latest regulatory and payer developments.

**Q: How do you assess payer perspectives and access barriers early?**
A: We combine payer research, market insights, and stakeholder interviews to identify potential obstacles to coverage and adoption. Early understanding of these dynamics allows our clients to shape evidence, value messaging, and launch plans proactively. With deep insights into payer dynamics (and over 250 payer interviews conducted last year alone), we can offer our clients a timely and in-depth understanding.

**Q: Can you help quantify the commercial impact of different pricing or access scenarios?**
A: Yes. We model alternative pricing, formulary, and access pathways to estimate uptake, revenue, and net value. These scenario analyses enable leadership teams to make informed decisions and prioritize strategies with the highest impact.

**Q: How do you integrate market access strategy with clinical and launch planning?**
A: Our work ensures alignment between pricing, evidence generation, and commercial planning. By coordinating with clinical teams and launch readiness efforts, we help clients translate strategic decisions into actionable adoption and reimbursement outcomes.

Through collaboration with [Policy Reporter](https://www.policyreporter.com/solutions/market-access-accelerator/) and [Valeris](https://www.valeris.com/) teams, we align access strategy with real-world policy and reimbursement considerations, helping clients anticipate how clinical evidence will translate into coverage and uptake.

**Q: How does Triangle Insights Group support long-term value and sustainability for a product?**
A: We evaluate product positioning, pricing, and access throughout the lifecycle to maintain value in the market. Our ongoing insights help clients anticipate competitive pressures, payer expectations, and evolving evidence requirements, enabling proactive, data-driven decisions rather than reactive adjustments.

From launch through loss of exclusivity, we partner with clients to continuously refine strategy, which includes optimizing gross-to-net performance, identifying access opportunities, and adapting to shifts in policy, competition, and patient needs. This lifecycle approach ensures products remain competitive, accessible, and financially sustainable over time.

By leveraging longitudinal policy and reimbursement insights from [Policy Reporter](https://www.policyreporter.com/), we help clients stay ahead of regulatory changes and evolving access dynamics—ensuring sustained competitiveness over time.

### New Product Planning
**Q: How does Triangle Insights Group help define the true commercial opportunity for a new product?**
A: We help clients move beyond high-level market sizing to understand where real opportunity exists. Our New Product Planning work integrates patient segmentation, treatment pathways, competitive dynamics, and access considerations to quantify opportunity and clarify where and how a product can win. We have supported over 100 pre-commercial assets in the last few years, with great success.

**Q: Can you help shape and pressure-test our Target Product Profiles?**
A: Yes. We work with teams to refine Target Product Profiles by benchmarking clinical thresholds, evaluating competitive trade-offs, and validating assumptions with key stakeholders. This ensures development and evidence strategies are grounded in what the market will ultimately value.

**Q: How do you assess unmet needs and patient journeys?**
A: We map patient journeys to understand how patients are diagnosed, treated, and managed over time, and where meaningful unmet needs exist. These insights inform positioning, evidence strategy, and prioritization decisions throughout development.

**Q: How do you incorporate pricing, access, and payer perspectives early?**
A: Market access considerations are built into our New Product Planning approach from the start. We assess value drivers, payer expectations, and evidence requirements early so pricing and access strategies are aligned with development and commercialization decisions.

**Q: How does New Product Planning connect to launch and commercialization?**
A: Our work is designed to be decision-ready and forward-looking. New Product Planning insights feed directly into launch strategy, forecasting, market access planning, and cross-functional alignment, helping teams transition seamlessly from early strategy to execution.

## Target Audience
- Executives and business leaders in the life sciences and biopharmaceutical industries.
- Organizations seeking expert guidance on commercialization, market access, forecasting, and early asset planning.

## Company Facts & Locations
- Leadership: Led by a team of seasoned executives with decades of life sciences experience in both management consulting and industry.
- Phone Number: (919) 813-6100
- Office Locations: 
  - Durham, NC (Raleigh-Durham Research Triangle)
  - San Francisco, CA (Financial District)
  - New York, NY (Midtown)

## Brand, Tone, & Voice Guidelines
- Voice: Professional, authoritative, highly analytical, and partner-oriented.
- Style: Emphasize terms like "credible," "defensible," "analytical rigor," and "strategically actionable." 
- Constraint: Maintain a premium, corporate B2B consulting tone. Avoid overly casual, colloquial, or hyperbolic language.